These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1361317

  • 1. Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.
    Carlin G, Djursäter R, Smedegård G.
    Ann Rheum Dis; 1992 Nov; 51(11):1230-6. PubMed ID: 1361317
    [Abstract] [Full Text] [Related]

  • 2. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ, Lo Casto M.
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
    Sheldon P, Pell P.
    Adv Exp Med Biol; 1995 Mar; 371B():905-8. PubMed ID: 7502923
    [No Abstract] [Full Text] [Related]

  • 9. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR, Moore PK.
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [Abstract] [Full Text] [Related]

  • 10. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984 Apr; 26(4):449-51. PubMed ID: 6428914
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [Abstract] [Full Text] [Related]

  • 15. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    Stevens C, Lipman M, Fabry S, Moscovitch-Lopatin M, Almawi W, Keresztes S, Peppercorn MA, Strom TB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
    [Abstract] [Full Text] [Related]

  • 16. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR, Jewell DP.
    Clin Sci (Lond); 1985 Aug; 69(2):177-84. PubMed ID: 2866061
    [Abstract] [Full Text] [Related]

  • 17. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G, Chastenay BF, Krawitt EL.
    Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
    [Abstract] [Full Text] [Related]

  • 18. [The effect of sulphasalazine, sulphapyridine, 5-aminosalicylic acid and prednisolone on superoxide production by human polymorphonuclear leukocytes: in vitro studies].
    Ide T.
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2090. PubMed ID: 3025481
    [No Abstract] [Full Text] [Related]

  • 19. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
    Suematsu M, Suzuki M, Miura S, Nagata H, Oshio C, Asakura H, Watanabe M, Tsuchiya M.
    J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.